IndiGo reshuffle part of plan to expand international operations

The airline is looking at executives with experience in international markets, sources have told Moneycontrol

Yaruqhullah Khan

April 01, 2022 / 19:09 IST

Representative Image

The churn at the top of InterGloble Aviation-owned IndiGo is part of India’s biggest airline’s plan to focus on expanding its international operations, sources close to the development have told Moneycontrol.

"The airline is looking to expand its international presence and is looking at executives with experience in international markets," one of the sources said.

On March 30, the company announced that Gaurav Negi would take over as the chief financial officer from Jiten Chopra.

The next day, chief commercial officer Willy Boulter said he would leave the airline in July. In an interview to Bloomberg Television, he said his age was one of the reasons for the decision to leave IndiGo and he was looking to take up a part-time role.

IndiGo had not yet decided on a replacement for Boulter and would be looking at top executives with international airlines, the source said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show